Memery Crystal CEO, Nick Davis to speak at IC3 Europe

Nick will be chairing the session entitled ‘The Path to Public Markets’, featuring Perry Antelman, CEO of Abacus; Alex Brooks the Senior Analyst at Canaccord Genuity; David Elsley CEO of Cardiol Therapeutics; Daryyl Jones CEO of Isracann BioSciences and Roby Zomer the Executive Director and CTO of MGC Pharmaceuticals. The discussion will explore the journey of public companies in North America on their route to listing.

IC3 is being hosted by the US Information Management Network (IMN) and Prohibition Partners, a leading source of independent data, intelligence and strategy for the cannabis industry. The event will explore the European Cannabis market and discuss the rapid growth forecast over the coming years, and is part of European Cannabis Week 2019.

Nick Davis, “I am looking forward to being a part of IC3 and European Cannabis Week 2019. The cannabis market in Europe is on the eve of rapid growth, and I am excited that Memery Crystal is leading UK law firm at the forefront of this emerging market”.

Find out more about what is happening at IC3 here.